| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Dyne Therapeutics, Inc. (DYN) has 7 insiders with recent SEC Form 4 filings, including 8 buys and 24 sells. DYN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 5.28M | $110.10M | - | |
| Dir | 1.16M | $24.19M | - | |
| CEO | 368.2K | $7.68M | -2,683 | |
| Other | 169.2K | $3.53M | -887 | |
| Other | 154.2K | $3.22M | -145 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 11, 2024 | Scalzo Richard William58 | SVP, Head Of Finance &Admin. | Sell | 1,468 | $31.89 | $46,814.52 | -1.4% | -13.1% | -59.6% | |
| Sep 6, 2024 | Scalzo Richard William58 | SVP, Head Of Finance &Admin. | Sale+OE | 126,074 | $32.15 | $4,052,851.36 | -38.1% | -16.0% | -56.9% | |
| Sep 5, 2024 | Kersten Dirk87 | Director | Sell | 1,577 | $35.03 | $55,242.31 | -0.4% | -12.5% | -57.7% | |
| Sep 4, 2024 | Cox John | CEO &President | Buy | 32,000 | $33.04 | $1,057,216.00 | +1,000% | -16.6% | -60.8% | |
| Aug 30, 2024 | Kersten Dirk87 | Director | Sell | 31,300 | $45.59 | $1,427,063.08 | -3.7% | -33.6% | -70.7% | |
| Aug 29, 2024 | Kersten Dirk87 | Director | Sell | 134,261 | $45.03 | $6,045,782.92 | -6.6% | -31.2% | -70.2% | |
| Aug 27, 2024 | Kersten Dirk87 | Director | Sell | 154,900 | $44.87 | $6,950,453.19 | -7.8% | -33.1% | -69.0% | |
| Aug 23, 2024 | Kersten Dirk87 | Director | Sell | 180,409 | $46.02 | $8,302,088.48 | -5.5% | -36.1% | -73.0% | |
| Aug 21, 2024 | Kersten Dirk87 | Director | Sell | 222,603 | $46.61 | $10,375,619.95 | -4.2% | -36.9% | -74.0% | |
| Aug 19, 2024 | High Susanna Gatti66 | Chief Operating Officer | Sell | 2,910 | $45.12 | $131,303.82 | -1.0% | -36.4% | -73.4% |